Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients.

Ducros J, Larifla L, Merault H, Foucan L.

Int J Nephrol. 2017;2017:1312547. doi: 10.1155/2017/1312547. Epub 2017 Sep 17.

2.

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic Sclerosis.

Muresan L, Petcu A, Muresan C, Rinzis M, Gusetu G, Pop D, Zdrenghea D, Rednic S.

Iran J Public Health. 2017 Jul;46(7):906-916.

3.

Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.

Li X, Kuznetsova T, Cauwenberghs N, Wheeler M, Maecker H, Wu JC, Haddad F, Dai H.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7089-7094. doi: 10.1073/pnas.1621457114. Epub 2017 Jun 19.

4.

Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood.

Yang X, Liu L, Hao Q, Zou D, Zhang X, Zhang L, Li H, Qiao Y, Zhao H, Zhou L.

PLoS One. 2017 Feb 2;12(2):e0171376. doi: 10.1371/journal.pone.0171376. eCollection 2017.

5.

Evaluating the Correlation between Serum NT-proBNP Level and Diastolic Dysfunction Severity in Beta-Thalassemia Major Patients.

Alizadeh B, Badiee Z, Mahmoudi M, Mohajery M.

J Tehran Heart Cent. 2016 Apr 13;11(2):68-72.

6.

Cocaine-associated increase of atrial natriuretic peptides: an early predictor of cardiac complications in cocaine users?

Casartelli A, Dacome L, Tessari M, Pascali J, Bortolotti F, Trevisan MT, Bosco O, Cristofori P, Tagliaro F.

Heart Asia. 2014 Jul 8;6(1):100-7. doi: 10.1136/heartasia-2013-010482. eCollection 2014.

7.

Heart failure with preserved ejection fraction.

ElGuindy A, Yacoub MH.

Glob Cardiol Sci Pract. 2012 Jul 17;2012(1):10. doi: 10.5339/gcsp.2012.10. eCollection 2012. Review.

8.

The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.

Lazo M, Rubin J, Clark JM, Coresh J, Schneider AL, Ndumele C, Hoogeveen RC, Ballantyne CM, Selvin E.

J Hepatol. 2015 Apr;62(4):841-7. doi: 10.1016/j.jhep.2014.11.024. Epub 2014 Nov 27.

9.

Prognostic significance of a multimarker strategy of biomarkers in acute heart failure.

Srinivas P, Manjunath CN, Banu S, Ravindranath KS.

J Clin Diagn Res. 2014 Sep;8(9):MC01-6. doi: 10.7860/JCDR/2014/9289.4783. Epub 2014 Sep 20.

10.
11.

Relationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.

Lu Z, Wang B, Wang Y, Qian X, Zheng W, Wei M.

Biomed Res Int. 2014;2014:106252. doi: 10.1155/2014/106252. Epub 2014 Aug 28.

12.

Body water distribution and risk of cardiovascular morbidity and mortality in a healthy population: a prospective cohort study.

Knudsen NN, Kjærulff TM, Ward LC, Sæbye D, Holst C, Heitmann BL.

PLoS One. 2014 Feb 3;9(2):e87466. doi: 10.1371/journal.pone.0087466. eCollection 2014.

13.

Chronic heart failure: we are fighting the battle, but are we winning the war?

Atherton JJ.

Scientifica (Cairo). 2012;2012:279731. doi: 10.6064/2012/279731. Epub 2012 Dec 20. Review.

15.

Prognostic value of plasma N-terminal pro-B-type natriuretic peptide concentration in patients with normal and impaired left ventricular systolic function undergoing surgery for abdominal aortic aneurysm.

Waliszek M, Waliszek-Iwanicka A, Grycewicz T, Jurowski P, Banach M, Rysz J, Goch A.

Arch Med Sci. 2011 Aug;7(4):642-7. doi: 10.5114/aoms.2011.24134. Epub 2011 Sep 2.

16.

Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.

Bertoni AG, Wagenknecht LE, Kitzman DW, Marcovina SM, Rushing JT, Espeland MA; Brain Natriuretic Peptide Subgroup of the Look AHEAD Research Group.

Obesity (Silver Spring). 2012 Jul;20(7):1511-8. doi: 10.1038/oby.2011.296. Epub 2011 Sep 29.

17.

Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus.

Goldenberg D, Miller E, Perna M, Sattar N, Welsh P, Roman MJ, Salmon JE.

Arthritis Rheum. 2012 Jan;64(1):316-7. doi: 10.1002/art.33374. No abstract available.

18.

Natriuretic Peptide system and cardiovascular disease.

Federico C.

Heart Views. 2010 Mar;11(1):10-5.

19.

Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.

Bajrić M, Baraković F, Kusljugić Z, Salkić N, Jahić E, Ascerić M, Ljuca F, Mrsić D, Smajić E, Caluk J, Hajrić R.

Bosn J Basic Med Sci. 2008 Aug;8(3):282-6.

20.

Utility of N terminal pro brain natriuretic peptide in elderly patients.

Sivakumar R, Wellsted D, Parker K, Lynch M, Ghosh P, Khan SA.

Postgrad Med J. 2006 Mar;82(965):220-3.

Supplemental Content

Support Center